de Sain-van der Velden Monique G M, van der Ham Maria, Jans Judith J, Visser Gepke, Prinsen Hubertus C M T, Verhoeven-Duif Nanda M, van Gassen Koen L I, van Hasselt Peter M
Department of Medical Genetics, UMC Utrecht, 85090, 3508AB, Utrecht, The Netherlands.
Department of Pediatric Gastroenterology and Metabolic Diseases, University Medical Centre (UMC) Utrecht, Utrecht, The Netherlands.
JIMD Rep. 2016;30:15-22. doi: 10.1007/8904_2016_531. Epub 2016 Feb 27.
The presence of increased urinary concentrations of both methylmalonic acid (MMA) and malonic acid (MA) is assumed to differentiate combined malonic and methylmalonic aciduria (CMAMMA), due to mutations in the ACSF3 gene, from other causes of methylmalonic aciduria (classic MMAemia). Detection of MA in urine, however, is challenging since excretion of MA can be easily missed. The objective of the study was to develop a method for quantification of MA in plasma to allow differentiation between CMAMMA and classic MMAemia.
Compound heterozygosity for mutations in the ACSF3 gene was detected in two female siblings using diagnostic exome sequencing. Urine (MMA and MA) was analyzed with GC/MS, while plasma was analyzed with UPLC-MS/MS. MA/MMA ratios were calculated.
Both patients had a severe psychiatric presentation (at the age of 6 years and 5.5 years, respectively) after a viral infection. MA excretion in the patients was only just above the highest control value in several samples. MA concentrations in plasma from the two patients were clearly above the highest value observed in control subjects. However, MA concentrations in plasma from patients with classic MMAemia were also elevated. Additional, calculation of MA/MMA ratio in plasma allowed to fully differentiate between CMAMMA and classic MMAemia.
Calculating the MA/MMA ratio in plasma allows differentiation between CMAMMA and classic MMAemia. The full clinical spectrum of CMAMMA remains to be delineated.
尿中甲基丙二酸(MMA)和丙二酸(MA)浓度升高被认为可将因ACSF3基因突变导致的丙二酸和甲基丙二酸联合尿症(CMAMMA)与甲基丙二酸尿症的其他病因(经典甲基丙二酸血症)区分开来。然而,尿中MA的检测具有挑战性,因为MA的排泄很容易被遗漏。本研究的目的是开发一种定量血浆中MA的方法,以区分CMAMMA和经典甲基丙二酸血症。
使用诊断性外显子组测序在两名女性同胞中检测到ACSF3基因突变的复合杂合性。尿样(MMA和MA)用气相色谱/质谱法分析,血浆用超高效液相色谱-串联质谱法分析。计算MA/MMA比值。
两名患者在病毒感染后均出现严重精神症状(分别为6岁和5.5岁)。患者的MA排泄量仅在几个样本中略高于最高对照值。两名患者血浆中的MA浓度明显高于对照受试者中观察到的最高值。然而,经典甲基丙二酸血症患者血浆中的MA浓度也有所升高。此外,计算血浆中的MA/MMA比值可完全区分CMAMMA和经典甲基丙二酸血症。
计算血浆中的MA/MMA比值可区分CMAMMA和经典甲基丙二酸血症。CMAMMA的完整临床谱仍有待描绘。